TY  - RPRT
TI  - Preclinical Prediction of Resistance and Optimization of Sequential Therapy for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors
AU  - Semba, K.
AU  - Takei, Y.
AU  - Kuroiwa, H.
AU  - Arai, C.
AU  - Doi, Y.
PY  - 2025
DO  - 10.1101/2025.05.26.656085
UR  - https://www.biorxiv.org/content/10.1101/2025.05.26.656085v1
ID  - 10.1101/2025.05.26.656085
ER  -